Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: Findings from the Women's Health Initiative (WHI)

Journal of Bone and Mineral Research

Volumn 25, Issue 4, 2010, Pages 873-881

  Carbone, Laura D ^a,b   Johnson, Karen C ^b   Robbins, John ^c   Larson, Joseph C ^d   Curb, J David ^e   Watson, Kathleen ^f   Gass, Margery ^g   LaCroix, Andrea Z ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Aging; Menopause; Population studies

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL PRACTICE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FALLING; FEMALE; FOLLOW UP; FRACTURE; HAZARD RATIO; HIP FRACTURE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; VERTEBRA FRACTURE;

ACCIDENTAL FALLS; AGED; ANTICONVULSANTS; BONE DENSITY; CLINICAL TRIALS AS TOPIC; FEMALE; FRACTURES, BONE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953404963     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091027     Document Type: Article

References (44)

1. Valsamis HA, Arora SK, Labban B, McFarlane SI. Antiepileptic drugs and bone metabolism. Nutr Metab (Lond). 2006;3:36.
2. Frediani F. Anticonvulsant drugs in primary headaches prophylaxis. Neurol Sci. 2004;25:S161-166. (Pubitemid 41461984)
3. Stefan H, Feuerstein TJ. Novel anticonvulsant drugs. Pharmacol Ther. 2007;113:165-183.
4. Petty SJ, O'Brien TJ, Wark JD. Anti-epileptic medication and bone health. Osteoporos Int. 2007;18:129-142.
5. Spector W, Shaffer T, Potter DE, Correa-de-Araujo R, Rhona Limcangco M. Risk factors associated with the occurrence of fractures in US nursing homes: resident and facility characteristics and prescription medications. J Am Geriatr Soc. 2007;55:327-333. (Pubitemid 46328116)
6. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163:949-957. (Pubitemid 36519740)
7. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45:1330-1337. (Pubitemid 39470036)
8. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767-773.
9. Kobau R, Zahran H, Thurman DJ, et al. Epilepsy surveillance among adults: 19 states, behavioral risk factor surveillance system, 2005. MMWR Surveill Summ. 2008;57:1-20.
10. Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs. Cleve Clin J Med. 2004;71:S42-48. (Pubitemid 41830287)
11. Takkouche B, Montes-Martinez A, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf. 2007;30:171-184. (Pubitemid 46193066)
12. Linde J, Molholm Hansen J, Siersbaek-Nielsen K, Frederiksen VF. Bone density and long-term anticonvulsant therapy. Br Med J. 1971;3:433.
13. Linde J, Molholm Hansen J, Siersbaek-Nielsen K, Fuglsang-Fredriksen V. Bone density in patients receiving long-term anticonvulsant therapy. Acta Neurol Scand. 1971;47:650-651.
14. Christiansen C, Rodbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J. 1973;4:695-701.
15. Stamp TC, Round JM, Rowe DJ, Haddad JG. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J. 1972;4:9-12.
16. Hahn TJ, Birge SJ, Scharp CR, Avioli LV. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest. 1972;51:741-748.
17. Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004;5:S3-15.
18. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;58:1348-1353. (Pubitemid 34507160)
19. Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs. 2001;15:633-642.
20. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989;69:990-1047. (Pubitemid 19184853)
21. Luukinen H, Kakonen SM, Pettersson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res. 2000;15:2473-2478.
22. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91:1769-1774. (Pubitemid 23127383)
23. Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50:1629-1637.
24. Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology. 2004;62:2051-2057. (Pubitemid 38738220)
25. Fife TD, Blum D, Fisher RS. Measuring the effects of antiepileptic medications on balance in older people. Epilepsy Res. 2006;70:103-109. (Pubitemid 44209223)
26. Fife TD, Sirven J. Antiepileptic drugs and their impact on balance. Aging Health. 2005;1:147-155.
27. Walia KS, Khan EA, Ko DH, Raza SS, Khan YN. Side effects of antiepileptics-a review. Pain Pract. 2004;4:194-203.
28. Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev. 2008;24:S52-57.
29. Wirrell EC. Epilepsy-related injuries. Epilepsia. 2006;47:79-86.
30. Mosekilde L, Hansen HH, Christensen MS, et al. Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short-term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol. Acta Med Scand. 1979;205:405-409.
31. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61-109.
32. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. New York: The McGraw-Hill Companies, Inc.; 2008.
33. Helms RA, Quan DJ, Herfindal ET, Gourley DR. In: Helms RA, Quan DJ, eds. Textbook of Therapeutics: Drug and Disease Management. 8th ed. Pennsylvania: Lippincott Williams & Wilkins; 2006.
34. Rose BD, Rush JM. UpToDate Online 16.2. 1992.
35. Lexi-Comp Online. 2008 [cited].
36. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178-187. (Pubitemid 29144458)
37. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama. 2002;288:321-333.
38. Hope OA, Zeber JE, Kressin NR, et al. New-onset geriatric epilepsy care: Race, setting of diagnosis, and choice of antiepileptic drug. Epilepsia. 2008.
39. Annegers JF, Melton LJ 3rd, Sun CA, Hauser WA. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia. 1989;30: 348-355.
40. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94:1244-1250.
41. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab. 2006;91:2980-2985. (Pubitemid 44271745)
42. Colon-Emeric CS, Pieper CF, Artz MB. Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? development and validation of a clinical tool. Osteoporos Int. 2002;13:955-961.
43. Walter LC, Lui LY, Eng C, Covinsky KE. Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc. 2003;51:50-55. (Pubitemid 36119934)
44. von Muhlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int. 2005;16:1721-1726. (Pubitemid 41790881)